BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15446565)

  • 1. [A resected case of thoracic esophageal cancer in which pCR was obtained using low-dose of nedaplatin (CDGP)/5-FU and radiotherapy].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H; Higashino M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1399-402. PubMed ID: 15446565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathologic complete response of thoracic esophageal cancer developing after gastrectomy to neoadjuvant low-dose nedaplatin (CDGP), 5-fluorouracil and radiotherapy].
    Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1023-7. PubMed ID: 16044966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of local advanced cervical esophageal cancer treated with concurrent radiochemotherapy followed by surgery].
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Takakita S; Kusumi F; Kato Y; Takeda H
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):2001-4. PubMed ID: 9350249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
    Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Narumiya K; Takasaki K; Mitsuhashi M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):803-7. PubMed ID: 12852347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T; Fuwa N; Kamata M; Furutani K; Tachibana H; Yamazaki T
    Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of nedaplatin, 5-FU, and leucovorin combined with radiation therapy in unresectable esophageal carcinoma].
    Futami R; Tajiri T; Miyashita M; Maruyama H; Makino H; Nomura T; Tateno A; Miyashita T; Sasajima K
    Gan To Kagaku Ryoho; 2003 May; 30(5):681-4. PubMed ID: 12795101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of complete response after neoadjuvant chemotherapy for advanced esophageal cancer with low-dose FP therapy].
    Muto A; Miyazawa M; Tsukada M; Ohtani S; Endoh H; Koyama K; Satoh M
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1315-7. PubMed ID: 16184931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resection of esophageal cancer infiltrating the left main bronchus following complete response to preoperative radiochemotherapy--a case report].
    Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1949-53. PubMed ID: 14650965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y; Kamikonya N; Inoue T; Koishi K; Yoshikawa R; Nakao K; Yagyu R; Nishiwaki M; Fujiwara M; Kojima S; Nakagawa K; Yamamura T
    Oncol Rep; 2005 Nov; 14(5):1177-82. PubMed ID: 16211282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.
    Kato H; Fukuchi M; Manda R; Nakajima M; Miyazaki T; Sohda M; Masuda N; Fukai Y; Tsukada K; Kuwano H
    Anticancer Res; 2003; 23(4):3493-8. PubMed ID: 12926096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Yano M; Yasuda T; Miyata H; Fujiwara Y; Takiguchi S; Monden M
    J Surg Oncol; 2005 Mar; 89(4):244-50; discussion 250. PubMed ID: 15726612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy].
    Yasuda T; Yano M; Takiguchi S; Kimura Y; Fujiwara Y; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1737-40. PubMed ID: 14619507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].
    Tomura K; Kogo M; Inoue T; Kaneko K; Imawari M; Yoneyama K; Kiuchi Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1807-13. PubMed ID: 18030014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent esophageal cancer with complete response to TS-1 chemotherapy].
    Watanabe T; Chinen T; Nakachi N; Nakamoto M; Uchima N; Hirata T; Hokama A; Kinjo N; Kinjo F; Fujita J
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):419-22. PubMed ID: 17353634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete remission of esophageal undifferentiated carcinoma with nedaplatin and 5-FU chemotherapy and endoesophageal brachytherapy].
    Nemoto H; Takeuchi S; Nagasaki H; Yoshizawa Y; Kikuchi H; Yagi H; Midorikawa T; Sanada Y; Kumada K; Iwashige M; Takizawa K; Tate G
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):263-7. PubMed ID: 12610877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of advanced esophageal cancer with para-aortic lymph node metastasis with complete response (CR) to combination chemotherapy including nedaplatin].
    Noda S; Kubo N; Tanaka H; Muguruma K; Yashiro M; Yamada N; Maeda K; Sawada T; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2451-3. PubMed ID: 20037453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.